Showing results (1961-1970 of 2,739) with videos related to
Sort By:
Pageof 274
Journal of Diabetes Research|October 2, 2024
Efficacy and Safety of Ertugliflozin Compared to Placebo in Patients With Type 2 Diabetes: An Updated Systematic Review and Meta-AnalysisA B M Kamrul-Hasan, Muhammad Shah Alam, Samir Kumar Talukder, et al.Journal of Diabetes Research|September 23, 2024
Preoperative Intravitreal Conbercept Injection Reduced Both Angiogenic and Inflammatory Cytokines in Patients With Proliferative Diabetic RetinopathyZijing Huang, Li Jia Chen, Dingguo Huang, et al.Journal of Diabetes Research|August 7, 2023
Impact of a Novel Hydrogel with Injectable Platelet-Rich Fibrin in Diabetic Wound HealingLimin Bai, Xiaowei Zhang, Xiaomei Li, et al.Journal of Diabetes Research|June 7, 2023
Achievement of Target Glycemic Goal with Simple Basal Insulin Regimen in Women with Gestational Diabetes: A Prospective Cohort StudyMisao Fukuoka, Ichiro Yasuhi, Hiroshi Yamashita, et al.Journal of Diabetes Research|May 30, 2023
Serum Uric Acid Levels Are Related to Diabetic Peripheral Neuropathy, Especially for Motor Conduction Velocity of Tibial Nerve in Type 2 Diabetes Mellitus PatientsHui Zhang, Carvalho Vladmir, Zhen Zhang, et al.Journal of Diabetes Research|February 19, 2026
Exploring the Use of Hybrid Closed-Loop Systems in People With Type 1 Diabetes and Their Partners: A Qualitative Evaluation From the NHS England PilotJennifer Hagan, Tomás P Griffin, Radhika Chauhan, et al.Journal of Diabetes Research|November 22, 2024
Understanding Experiences of Diabetes Distress: A Systematic Review and Thematic SynthesisLouise Anne Morales-Brown, Guillermo Perez Algorta, Yakubu SalifuJournal of Diabetes Research|November 21, 2024
Total Water-Soluble Flavonoids From Lithocarpus litseifolius (Hance) Chun (Sweet Tea) Improve Glucose Homeostasis Through Multitarget Signalling in GDM MiceJunfei Xu, Fenfang Zhang, Huanhuan Li, et al.Journal of Diabetes Research|October 21, 2024
Empagliflozin Use Is Associated With Lower Risk of All-Cause Mortality, Hospitalization for Heart Failure, and End-Stage Renal Disease Compared to DPP-4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) StudyGisle Langslet, Thomas Nyström, Dorte Vistisen, et al.Journal of Diabetes Research|May 30, 2026
Caffeoylquinic Acids From Lonicera japonica Thunb. as Hypoglycemic Agents: Network Pharmacology and Pharmacological ValidationYiyi Ye, Dawei Xu, Shilu Zhang, et al.Pageof 274